Holding(s) in Company

RNS Number : 7901P

Dechra Pharmaceuticals PLC

31 March 2009

 



For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Dechra Pharmaceuticals Plc GB0009633180

2. Reason for notification (yes/no)
An acquisition or disposal of voting rights	X
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify): Transparency obligations directive - notification of existing previously disclosed position

3. Full name of person(s) subject to notification obligation:	Norges Bank
4. Full name of shareholder(s) (if different from 3):	N/A
5. Date of transaction (and date on which the threshold is crossed or reached if different):	27th March 2009
6. Date on which issuer notified:	30th March 2009
7. Threshold(s) that is/are crossed or reached:	3%

8: Notified Details                                                 Acquisition of shares increasing                                                                                      holding above the 3% threshold
A: Voting rights attached to shares
Class/type of shares If possible use ISIN code	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of shares	Number of voting rights	Number of shares	Number of voting rights		Percentage of voting rights
				Direct	Indirect	Direct	Indirect
GB0009633180	1,963,363	1,963,363	1,966,224	1,966,224		3.00%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ conversion period/date	No. of voting rights that may be acquired (if the instrument exercised/converted)	Percentage of voting rights
N/A	N/A	N/A	N/A	N/A

Total (A+B)
Number of voting rights	Percentage of voting rights
1,966,224	3.00%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

N/A

Proxy Voting:
10. Name of proxy holder:	Norges Bank
11. Number of voting rights proxy holder will cease to hold:	N/A
12. Date on which proxy holder will cease to hold voting rights:	N/A

13. Additional information:	None
14 Contact name:	Robert Cook
15. Contact telephone number:	0047 24073120

For notes on how to complete form TR-1 please see the FSA website. 

 

END

 

 

HOLKGGFFRMVGLZG